Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats

S. Yakar, H. Domene, R. Meidan, F. Cassorla, I. Gilad, I. Koch, Z. Laron, C. T. Roberts, D. LeRoith, R. Eshet

    Research output: Contribution to journalArticle

    13 Scopus citations


    Growth and development of the spleen involves the growth hormone (GH)/insulin-like growth factor-I IGF-I) axis. To evaluate the molecular mechanism of these effects we studied the effect of hypophysectomy (Hx) and GH replacement therapy on the expression of IGF-I, the IGF-I receptor and IGF-binding protein-2 (IGFBP-2) in juvenile rats. Hx resulted in a 30% reduction in body weight. GH replacement therapy for seven days partially prevented these effects. IGF-I mRNA levels were reduced 30% by Hx, IGFBP-2 mRNA levels fell 50% whereas IGF-I receptor mRNA levels were unaffected. GH therapy prevented the reduction in IGF-I and IGFBP-2 mRNA levels. These results suggest that the GH effect on splenic growth and development is via local (paracrine) IGF-I expression, in addition to any effect by circulating (endocrine) IGF-I.

    Original languageEnglish (US)
    Pages (from-to)363-366
    Number of pages4
    JournalHormone and Metabolic Research
    Issue number8
    StatePublished - Jan 1 1994



    • Gene expression
    • Growth hormone
    • IGF-I
    • Spleen

    ASJC Scopus subject areas

    • Endocrinology, Diabetes and Metabolism
    • Biochemistry
    • Endocrinology
    • Clinical Biochemistry
    • Biochemistry, medical

    Cite this